VolitionRX Ltd (NYSE American:VNRX)
| 2.64 Delayed Data As of Jan 27 |  +0.01 / +0.38%Today’s Change | 1.31 Today|||52-Week Range 3.30 | +8.64% Year-to-Date |
Latest VNRX News | Press Releases
No recent news for VolitionRX Ltd.
Today’s Trading
| Previous close | 2.63 |
| Today’s open | 2.66 |
| Day’s range | 2.63 - 2.66 |
| Volume | 52,208 |
| Average volume (3 months) | 130,038 |
| Market cap | $132.3M |
Data as of 3:59pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | -13.28% |
| Earnings growth (this year) | -12.55% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +570.25% |
| P/E ratio | NM |
| Price/Sales | 1,836.39 |
| Price/Book | 6.89 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CELUCelularity Inc | 0.00 | 0.00% |
| ---- | ||
| ---- | ||
| ---- |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | March 10, 2023 |
| EPS forecast (this quarter) | -$0.15 |
| Annual revenue (last year) | $90.0K |
| Annual profit (last year) | -$26.8M |
| Net profit margin | -29,782.49% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Henderson, Nevada |
Forecasts
